Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Tabersonine Monoacetate
1. Tabersonin
2. 4429-63-4
3. (-)-tabersonine
4. Mn955k48nb
5. Chebi:16776
6. Aspidospermidine-3-carboxylic Acid, 2,3,6,7-tetradehydro-, Methyl Ester, (5alpha,12beta,19alpha)-
7. (5alpha,12beta,19alpha)-2,3,6,7-tetradehydroaspidospermidine-3-carboxylic Acid, Methyl Ester
8. Methyl (5alpha,12beta,19alpha)-2,3,6,7-tetradehydroaspidospermidine-3-carboxylate
9. Methyl 2,3,6,7-tetradehydro-5alpha,12beta,19alpha-aspidospermidine-3-carboxylate
10. Einecs 224-615-0
11. Brn 0050163
12. Devil's Claw Extract
13. Unii-mn955k48nb
14. 4-25-00-00997 (beilstein Handbook Reference)
15. Schembl829379
16. Amy596
17. Chembl2011511
18. Tabersonine, >=95% (hplc)
19. Dtxsid30196102
20. Hms3887m03
21. Hy-n1431
22. Mfcd28140545
23. Nsc815334
24. S9427
25. Zinc56871302
26. Akos015896776
27. Ccg-267873
28. Nsc-815334
29. 3a-ethyl-3a,4,6,11,12,13a-hexahydro-1h-indolizino[8,1-cd]carbazole-5-carboxylic Acid Methyl Ester
30. Ac-26458
31. Aspidospermidine-3-carboxylic Acid, 2,3,6,7-tetradehydro-, Methyl Ester, (5.alpha.,12.beta.,19.alpha.)-
32. Aspidospermidine-3-carboxylic Acid, 2,3,6,7-tetrahydro-, Methyl Ester, (5-alpha,12-beta,19-alpha)-
33. Cs-0016859
34. C09244
35. Q21099578
36. 1h-indolizino(8,1-cd)carbazole-5-carboxylic Acid, 3a-ethyl-3a,4,6,11,12,13a-hexahydro-, Methyl Ester
37. Aspidospermidine-3-carboxylic Acid, 2,3,6,7-tetradehydro-, Methyl Ester, (5.alpha.,12r,19.alpha.)-
38. Methyl (1r,12r,19s)-12-ethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,9,13-pentaene-10-carboxylate
| Molecular Weight | 336.4 g/mol |
|---|---|
| Molecular Formula | C21H24N2O2 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 336.183778013 g/mol |
| Monoisotopic Mass | 336.183778013 g/mol |
| Topological Polar Surface Area | 41.6 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 669 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Tabersonine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tabersonine, including repackagers and relabelers. The FDA regulates Tabersonine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tabersonine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tabersonine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tabersonine supplier is an individual or a company that provides Tabersonine active pharmaceutical ingredient (API) or Tabersonine finished formulations upon request. The Tabersonine suppliers may include Tabersonine API manufacturers, exporters, distributors and traders.
click here to find a list of Tabersonine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Tabersonine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tabersonine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tabersonine GMP manufacturer or Tabersonine GMP API supplier for your needs.
A Tabersonine CoA (Certificate of Analysis) is a formal document that attests to Tabersonine's compliance with Tabersonine specifications and serves as a tool for batch-level quality control.
Tabersonine CoA mostly includes findings from lab analyses of a specific batch. For each Tabersonine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tabersonine may be tested according to a variety of international standards, such as European Pharmacopoeia (Tabersonine EP), Tabersonine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tabersonine USP).
LOOKING FOR A SUPPLIER?
